Drug Shortage Report for APO-DESVENLAFAXINE

Last updated on 2018-07-03 History
Report ID 38815
Drug Identification Number 02466996
Brand name APO-DESVENLAFAXINE
Common or Proper name DESVENLAFAXINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) DESVENLAFAXINE
Strength(s) 100MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100 BTL & 30 BTL
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-02-01
Estimated end date 2018-07-31
Actual end date 2018-06-29
Shortage status Resolved
Updated date 2018-07-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-07-03 French Compare
v9 2018-07-03 English Compare
v8 2018-04-16 French Compare
v7 2018-04-16 English Compare
v6 2018-03-13 French Compare
v5 2018-03-13 English Compare
v4 2018-03-05 French Compare
v3 2018-03-05 English Compare
v2 2018-02-06 French Compare
v1 2018-02-06 English Compare

Showing 1 to 10 of 10